𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine

✍ Scribed by Hana Závadová; Vladimír Vonka; Ervin Adam; Eva Domorázková; Fred M. Davenport


Publisher
Springer Vienna
Year
1972
Tongue
English
Weight
640 KB
Volume
36
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Influenza virus H5N1 hemagglutinin (HA)
✍ Theodore Skarlas; Stella Zevgiti; Karoline Droebner; Eugenia Panou-Pomonis; Oliv 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

## Abstract The influenza virus, major surface glycoprotein hemagglutinin (HA) is one of the principal targets for the development of protective immunity. Aiming at contributing to the development of a vaccine that remains the first choice for prophylactic intervention, a reconstituted model of HA,

Immunogenicity and safety of influenza v
✍ Jennifer C.C. deBruyn; Robert Hilsden; Kevin Fonseca; Margaret L. Russell; Gilaa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

Background: Protection against vaccine-preventable diseases is important in inflammatory bowel disease (IBD) because of increased susceptibility and severity of infection with immunosuppressive therapy. However, immunosuppressive therapy may affect vaccine response. This study aimed to evaluate immu

Immunogenicity of influenza A/USSR (H1N1
✍ Arthur L. Frank; W. Paul Glezen; Thomas R. Cate; Robert G. Webster 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

## Abstract Purified subunit vaccines (HANAflu) containing 20 /xg of hemagglutinin of influenza A/USSR/90/77 (H1N1) alone or with 1–5% whole virus were compared to commercially available vaccines for reactogenicity and immunogenicity in unprimed young adults. Reactions to all vaccines were minimal.